Bortezomib, Mitoxantrone Hydrochloride Liposome, and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Multi‐Center, Open‐Label Phase I Trial
Guangzhong Yang, Da Gao, Wei Wang, Li Bao et al.
Journal
Cancer Medicine
Topics
Multiple Myeloma Research and Treatments
article
Bortezomib, Mitoxantrone Hydrochloride Liposome, and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Multi‐Center, Open‐Label Phase I Trial
Guangzhong Yang, Da Gao, Wei Wang, Li Bao, Wenming Chen, Baijun Fang, Liping Su, Ya‐Lan Zhou, Jinqiao Zhang
article en
Abstract
No abstract available for this paper.
Publication Tag
Cancer MedicineVol. 14(8)
Institutions
Hebei Medical University (CN), Harbin Medical University (CN), Capital Medical University (CN), Peking University (CN), Beijing Chao-Yang Hospital, Capital Medical University (CN), Beijing Jishuitan Hospital (CN), Zhengzhou University (CN), Third Hospital of Hebei Medical University (CN), Shanxi Provincial Cancer Hospital (CN), Second Affiliated Hospital of Harbin Medical University (CN), Henan Cancer Hospital (CN), Inner Mongolia Medical University (CN)